Analysis of circulating hormone levels after sleeve gastrectomy in severe obese patients

Analysis of circulating hormone levels after sleeve gastrectomy in severe obese patients - Hormone analysis after sleeve gastrectomy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028221

Enrollment

Registered

2017-08-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe obese patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: This study intends for severe obese patients (BMI>35) complicated with diabetes, hypertension or dislipidemia.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Analyze circulating hormone levels (FGF21, Ghrelin, Glucagon, GLP-1) before and after sleeve gastrectomy on severe obesity.	—

Countries

Japan

Contacts

Public ContactMITSURU NISHIYAMA

Kochi Medical School, Kochi University Department of Endocrinology, Metabolism & Nephrology

nisiyamm@kochi-u.ac.jp088-880-2343

Outcome results